Wound Healing Partnering 2009-2014

Published: August 2014
No. of Pages: 250
   

"Delivery of this report will take 1-3 days after purchase."

Wound Healing Partnering 2009-2014 report provides understanding and access tthe wound healing partnering deals and agreements entered intby the worlds leading healthcare companies.

  • Trends in wound healing partnering deals
  • Top wound healing deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

Wound Healing Partnering 2009-2014 provides understanding and access tthe wound healing partnering deals and agreements entered intby the worlds leading healthcare companies.

The report provides an analysis of wound healing partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right tlicense the licensors wound healing technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases dnot.

This data driven report contains over 236 links tonline copies of actual liver disease deals and contract documents as submitted tthe Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers tnumerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability tderive value from the deal.

The initial chapters of this report provide an orientation of HIV partnering trends.

Chapter 1 provides an introduction tthe report, whilst chapter 2 provides an overview of the trends in wound healing partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading wound healing deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract.

Chapter 4 provides a comprehensive directory of wound healing partnering deals signed and announced since 2009. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink tan online version of the deal record, and where available the contract document, providing easy access teach contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the research, development and commercialization of wound healing technologies and products.

Report scope

Wound Healing Partnering 2009-2014 is intended tprovide the reader with an in-depth understanding and access twound healing trends and structure of deals entered intby leading companies worldwide.

This data driven report includes:

  • Trends in wound healing dealmaking in the biopharma industry since 2009
  • Access tsummary headline, upfront, milestone and royalty data
  • The leading wound healing deals by value since 2009

In Wound Healing Partnering 2009-2014, the available deals are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Company A-Z
  • Industry sector
  • Stage of development at signing
  • Deal component type
  • Technology type

Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Benefits

Wound Healing Partnering 2009-2014 provides the reader with the following key benefits:

  • In-depth understanding of wound healing deal trends since 2009
  • Access tsummary headline, upfront, milestone and royalty data
  • Comprehensive access tover 230 actual wound healing deals entered intby the world’s biopharma companies since 2009
  • Insight intkey deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence tassess suitability of your proposed deal terms for partner companies

Wound Healing Partnering 2009-2014

Table of Contents

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in wound healing partnering
2.1. Introduction
2.2. Wound healing partnering over the years
2.3. Bigpharma wound healing dealmaking activity
2.4. Wound healing partnering by deal type
2.5. Wound healing partnering industry sector
2.6. Wound healing partnering by stage of development
2.7. Wound healing partnering by technology type
2.8. Disclosed financial deal terms for wound healing partnering
2.8.1 Wound healing headline values
2.8.2 Wound healing upfront payments
2.8.3 Wound healing milestone payments
2.8.4 Wound healing royalty rates

Chapter 3 – Leading wound healing deals
3.1. Introduction
3.2. Top wound healing deals by value
3.3. Top wound healing deals involving bigpharma

Chapter 4 – Dealmaking directory
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines

Chapter 5 – Partnering resource center
5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices
Appendix 1 – Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports

List of Figures

Figure 1: Wound healing partnering since 2009
Figure 2: Bigpharma – top 50 – wound healing deals 2009 to 2014
Figure 3: Bigpharma wound healing deal frequency – 2009 to 2014
Figure 4: Wound healing partnering by deal type since 2009
Figure 5: Wound healing partnering by industry sector since 2009
Figure 6: Wound healing partnering by stage of development since 2009
Figure 7: Wound healing partnering by technology type since 2009
Figure 8: Wound healing deals with a headline value
Figure 9: Wound healing deals with upfront payment values
Figure 10: Wound healing deals with milestone payments
Figure 11: Wound healing deals with royalty rates, %
Figure 12: Top wound healing deals by value since 2009
Figure 13: Top wound healing deals signed by bigpharma value since 2009
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions

Published By: Current Partnering
Product Code: Current Partnering96


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100